DK2800567T3 - En inhalator omfattende en tiotropium-indeholdende-sammensætning - Google Patents

En inhalator omfattende en tiotropium-indeholdende-sammensætning

Info

Publication number
DK2800567T3
DK2800567T3 DK12805442.6T DK12805442T DK2800567T3 DK 2800567 T3 DK2800567 T3 DK 2800567T3 DK 12805442 T DK12805442 T DK 12805442T DK 2800567 T3 DK2800567 T3 DK 2800567T3
Authority
DK
Denmark
Prior art keywords
tiotropium
containing composition
inhalator
inhalator including
composition
Prior art date
Application number
DK12805442.6T
Other languages
English (en)
Inventor
Xian-Ming Zeng
Derek Fenlon
Original Assignee
Teva Branded Pharmaceutical Prod R & D Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45788842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2800567(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Branded Pharmaceutical Prod R & D Inc filed Critical Teva Branded Pharmaceutical Prod R & D Inc
Application granted granted Critical
Publication of DK2800567T3 publication Critical patent/DK2800567T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0091Inhalators mechanically breath-triggered
    • A61M15/0095Preventing manual activation in absence of inhalation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
DK12805442.6T 2011-12-19 2012-12-12 En inhalator omfattende en tiotropium-indeholdende-sammensætning DK2800567T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161577314P 2011-12-19 2011-12-19
GB201200504A GB201200504D0 (en) 2011-12-19 2012-01-13 An inhaler
PCT/EP2012/075230 WO2013092345A1 (en) 2011-12-19 2012-12-12 An inhaler comprising a tiotropium-containing-composition

Publications (1)

Publication Number Publication Date
DK2800567T3 true DK2800567T3 (da) 2017-11-06

Family

ID=45788842

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12805442.6T DK2800567T3 (da) 2011-12-19 2012-12-12 En inhalator omfattende en tiotropium-indeholdende-sammensætning
DK12196726.9T DK2606892T3 (da) 2011-12-19 2012-12-12 Inhalator omfattende en tiotropium-indeholdende sammensætning

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK12196726.9T DK2606892T3 (da) 2011-12-19 2012-12-12 Inhalator omfattende en tiotropium-indeholdende sammensætning

Country Status (22)

Country Link
US (1) US20140373832A1 (da)
EP (2) EP2800567B1 (da)
JP (1) JP2015502220A (da)
KR (2) KR101629119B1 (da)
CN (1) CN104010640A (da)
AR (1) AR089597A1 (da)
AU (1) AU2012358128B2 (da)
BR (1) BR112014014536A2 (da)
CA (1) CA2856054C (da)
DK (2) DK2800567T3 (da)
EA (1) EA029047B1 (da)
ES (2) ES2593281T3 (da)
GB (1) GB201200504D0 (da)
HK (2) HK1200341A1 (da)
HU (2) HUE030015T2 (da)
IL (1) IL232945B (da)
MX (1) MX357619B (da)
PL (2) PL2606892T3 (da)
TW (1) TWI524905B (da)
UY (1) UY34526A (da)
WO (1) WO2013092345A1 (da)
ZA (1) ZA201403042B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
EP2819669B1 (de) * 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Neue treibgashaltige tiotropium-formulierung
US9636425B2 (en) * 2012-09-18 2017-05-02 Focal Point Technologies, Llc Method of dry dye delivery for staining the eye
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US20190054010A1 (en) * 2015-10-29 2019-02-21 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
EP3393566A2 (en) 2015-12-21 2018-10-31 3M Innovative Properties Company Dose release firing systems and medicinal inhalers comprising same
EP3393562B1 (en) 2015-12-21 2021-08-11 Kindeva Drug Delivery L.P. Medicinal inhalers
WO2017112451A1 (en) * 2015-12-21 2017-06-29 3M Innovative Properties Company Auto-reset dose release firing systems, medicinal inhalers comprising same, and methods of using same
GB2553535A (en) 2016-09-07 2018-03-14 3M Innovative Properties Co Trigger mechansim for an inhaler
GB2553534A (en) * 2016-09-07 2018-03-14 3M Innovative Properties Co Trigger mechanism for an inhaler
GB201702408D0 (en) 2017-02-14 2017-03-29 Norton (Waterford) Ltd Inhalers and related methods
GB201702407D0 (en) 2017-02-14 2017-03-29 Norton (Waterford) Ltd Inhalers and related methods
EP3813797A4 (en) 2018-06-27 2022-03-30 Kindeva Drug Delivery L.P. TIOTROPIUM FORMULATION AND INHALER
FR3089127B1 (fr) * 2018-11-30 2020-11-20 Aptar France Sas Dispositif de distribution de produit fluide synchronisé avec l'inhalation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9026191D0 (en) 1990-12-01 1991-01-16 Harris Pharma Ltd Breath actuated dispensing device
GB2264238A (en) * 1992-05-29 1993-08-25 Norton Healthcare Ltd Medicament inhalor device
WO1994013262A1 (en) 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
AU5070100A (en) * 2000-05-22 2001-12-03 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
US6553988B1 (en) 2000-06-09 2003-04-29 Norton Healthcare, Inc. Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber
DE10214263A1 (de) 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7311894B2 (en) * 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
WO2004054580A1 (en) * 2002-12-16 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing hfc solution formulations
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
EP2201934A1 (en) * 2008-12-23 2010-06-30 CHIESI FARMACEUTICI S.p.A. Tiotropium aerosol formulation products with improved chemical stability
EP2501363B1 (en) 2009-11-17 2015-01-14 Cipla Limited Inhalation solutions

Also Published As

Publication number Publication date
EP2800567B1 (en) 2017-09-27
MX357619B (es) 2018-07-17
KR20150118195A (ko) 2015-10-21
IL232945B (en) 2018-05-31
NZ624160A (en) 2016-05-27
UY34526A (es) 2014-07-31
PL2800567T3 (pl) 2018-04-30
PL2606892T3 (pl) 2017-02-28
EP2606892A1 (en) 2013-06-26
GB201200504D0 (en) 2012-02-22
HUE030015T2 (en) 2017-04-28
AR089597A1 (es) 2014-09-03
ES2593281T3 (es) 2016-12-07
CA2856054A1 (en) 2013-06-27
HUE034667T2 (en) 2018-02-28
TW201341000A (zh) 2013-10-16
KR20140096159A (ko) 2014-08-04
US20140373832A1 (en) 2014-12-25
EA029047B1 (ru) 2018-02-28
MX2014007358A (es) 2014-11-21
TWI524905B (zh) 2016-03-11
AU2012358128B2 (en) 2015-09-17
HK1200341A1 (en) 2015-08-07
HK1200117A1 (en) 2015-07-31
BR112014014536A2 (pt) 2017-06-13
IL232945A0 (en) 2014-07-31
EP2606892B1 (en) 2016-08-24
NZ711668A (en) 2017-01-27
KR101629119B1 (ko) 2016-06-09
DK2606892T3 (da) 2016-09-26
WO2013092345A1 (en) 2013-06-27
ES2644572T3 (es) 2017-11-29
EA201491205A1 (ru) 2014-10-30
CN104010640A (zh) 2014-08-27
CA2856054C (en) 2016-11-22
AU2012358128A1 (en) 2014-05-22
EP2800567A1 (en) 2014-11-12
ZA201403042B (en) 2016-08-31
JP2015502220A (ja) 2015-01-22

Similar Documents

Publication Publication Date Title
SMT201600400B (it) Inalatore
CO6811828A2 (es) Nebulizador
DK2800567T3 (da) En inhalator omfattende en tiotropium-indeholdende-sammensætning
EP2740370A4 (en) Cigarette
BR112014002399A2 (pt) conjunto
LT2742151T (lt) Polimerazės kompozicija
BR112013013026A2 (pt) inalador
BR112013022112A2 (pt) composição
BR112013022102A2 (pt) composição
DK2686017T3 (da) Oftalmisk sammensætning
BR112014004395A2 (pt) composição
BR112014029111A2 (pt) inalador
DE102011100082A8 (de) Traygreifvorrichtung
EP2761267A4 (en) CALIBRATION OF A BREATHING ANALYZER
BR112014002724A8 (pt) inalador de pó
EP2542285A4 (en) INHALER
CO6870021A2 (es) Conjunto dispensador
BR112014000879A2 (pt) deflegmador
EP2692252A4 (en) CIGARETTE
CO6960543A2 (es) 2-tiopirimidinonas
BR112013033808A2 (pt) composição
SMT201600465B (it) Dispositivo di inalazione
EP2730619A4 (en) COMPOSITION
EP2769718A4 (en) MEDICAL COMPOSITION
CO6970601A2 (es) Nueva combinación